Stockreport

US FDA declines to approve Corcept's drug for rare hormonal disorder [Yahoo! Finance]

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF Shares ?of the drugmaker were down 48% at $36.41. The company said the FDA could not arrive at a ?favorable benefit-risk assessment for the hormone-blocking oral trea [Read more]